Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma. [electronic resource]
Producer: 20170925Description: 1168-1176 p. digitalISSN:- 1555-8576
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Cell Growth Processes -- drug effects
- Child, Preschool
- Cisplatin -- administration & dosage
- Drug Synergism
- Female
- Hep G2 Cells
- Hepatoblastoma -- drug therapy
- Histone Deacetylase Inhibitors -- administration & dosage
- Histone Deacetylases -- biosynthesis
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Risk Factors
- Transcriptome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.